![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Horiuchi, K Takeyasu, MM Mouradian, PA Jose and RA Felder
Department of Pathology, University of Virginia Medical Center, Charlottesville 22908.
We stably expressed the rat D1A dopamine receptor in mouse fibroblast LTK- cells and obtained specific ligand binding and functional activity characteristic of the D1A dopamine receptor coupled to stimulation of adenylyl cyclase. In the transfected cells, the selective D1 agonist fenoldopam caused a concentration-dependent inhibition of Na+/K(+)- ATPase activity, achieving maximum inhibition of approximately 30%. The latter was abolished by the selective D1 antagonist (+)-SCH 23390 and by the specific protein kinase A inhibitor protein kinase inhibitor-(6- 22) amide. In the nontransfected cells, fenoldopam did not affect Na+/K(+)-ATPase activity. 8-Chlorophenylthio-cAMP inhibited Na+/K(+)- ATPase activity in both transfected and nontransfected cells; this effect was blocked by protein kinase inhibitor-(6-22). These results indicate that the inhibition of Na+/K(+)-ATPase activity induced by agonist occupancy of D1A receptors is mediated by protein kinase A.
This article has been cited by other articles:
|
|
 |
|
  C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hussain and M. F. Lokhandwala Renal Dopamine Receptors and Hypertension Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gomes, M. A. Vieira-Coelho, and P. Soares-da-Silva Ouabain-insensitive acidification by dopamine in renal OK cells: primary control of the Na+/H+ exchanger Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R10 - R18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Blanco and R. W. Mercer Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function Am J Physiol Renal Physiol, November 1, 1998; 275(5): F633 - F650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sun, T. W. Wilborn, and J. A. Schafer Dopamine D4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct Am J Physiol Renal Physiol, November 1, 1998; 275(5): F742 - F751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. O'Connell, C. J. Vaughan, A. M. Aherne, S. J. Botkin, Z.-Q. Wang, R. A. Felder, and R. M. Carey Expression of the Dopamine D3 Receptor Protein in the Rat Kidney Hypertension, November 1, 1998; 32(5): 886 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Jose, L. D. Asico, G. M. Eisner, F. Pocchiari, C. Semeraro, and R. A. Felder Effects of costimulation of dopamine D1- and D2-like receptors on renal function Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R986 - R994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hussain and M. F. Lokhandwala Renal Dopamine Receptor Function in Hypertension Hypertension, August 1, 1998; 32(2): 187 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ozono, D. P. O'Connell, Z.-Q. Wang, A. F. Moore, H. Sanada, R. A. Felder, and R. M. Carey Localization of the Dopamine D1 Receptor Protein in the Human Heart and Kidney Hypertension, September 1, 1997; 30(3): 725 - 729. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Belusa, Z.-M. Wang, T. Matsubara, B. Sahlgren, I. Dulubova, A. C. Nairn, E. Ruoslahti, P. Greengard, and A. Aperia Mutation of the Protein Kinase C Phosphorylation Site on Rat alpha 1 Na+,K+-ATPase Alters Regulation of Intracellular Na+ and pH and Influences Cell Shape and Adhesiveness J. Biol. Chem., August 8, 1997; 272(32): 20179 - 20184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Yu, GilbertM. Eisner, I. Yamaguchi, M.M. Mouradian, RobinA. Felder, and PedroA. Jose Dopamine D1A Receptor Regulation of Phospholipase C Isoform J. Biol. Chem., August 9, 1996; 271(32): 19503 - 19508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ozono, D. P. O'Connell, C. Vaughan, S. J. Botkin, S. F. Walk, R. A. Felder, and R. M. Carey Expression of the Subtype 1A Dopamine Receptor in the Rat Heart Hypertension, March 1, 1996; 27(3): 693 - 703. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
